Investigating the Role of Anti-TPO Antibodies in HIV-Associated Thrombocytopenia before and after Initiation of HAART: A Case-Control Longitudinal Study
This longitudinal, case-control study aimed to investigate the role of thrombopoietin (TPO) and anti-TPO antibodies in HIV-associated thrombocytopenia, focusing on the changes seen before and after the initiation of highly active antiretroviral therapy (HAART). Patients were assessed before and at l...
Main Authors: | Aristotelis Tsiakalos, John G. Routsias, Georgios Schinas, Sarah Georgiadou, Nikolaos V. Sipsas, Karolina Akinosoglou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/11/2226 |
Similar Items
-
Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP)
by: Rick Kapur, et al.
Published: (2020-04-01) -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
by: Alhossain A. Khalafallah, et al.
Published: (2012-01-01) -
Serum thrombopoietin and cMpl expression in thrombocytopenia of different etiologies
by: Fabrizio Vianello, et al.
Published: (2014-03-01) -
Prevalence and predictors of thrombocytopenia among HAART naive HIV positive patients at Ambo University Referral Hospital
by: Meaza Adugna Ayanaw, et al.
Published: (2022-05-01) -
Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study
by: Yu Liu, et al.
Published: (2020-09-01)